Form 8-K - Current report:
SEC Accession No. 0001193125-13-396019
Filing Date
2013-10-10
Accepted
2013-10-10 08:17:34
Documents
3
Period of Report
2013-10-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d611326d8k.htm 8-K 15330
2 EX-99.1 d611326dex991.htm EX-99.1 8695
3 GRAPHIC g611326g46z98.jpg GRAPHIC 3569
  Complete submission text file 0001193125-13-396019.txt   30295
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 131144639
SIC: 2834 Pharmaceutical Preparations